Medical Meetings

Our success as a next-generation BioPharma company will be measured by the difference we can make in the lives of patients facing serious disease. Members of the press may learn more about our company, our philanthropy and our focus on innovative medicines by viewing these resources.

BMS at ASCO and EHA 2022

At this year's ASCO and EHA meetings, we shared research across immuno-oncology, hematology and cell therapy that underscores our efforts in delivering long-term survival and improved outcomes for patients.

BMS at Immunology Meetings

At this year's meetings across rheumatology, gastroenterology, dermatology and neurology, we shared data showcasing our commitment to advancing pathbreaking science and innovation for advancing care for people living with immune-mediated diseases. 

BMS at ACR Convergence 2022 >

The American College of Rheumatology (ACR) Convergence 2022 meeting is an important opportunity to share the latest research for people living with immune-mediated rheumatic diseases.

BMS at ACG 2022 >

The American College of Gastroenterology (ACG) 2022 annual meeting is a chance to demonstrate the latest advances in gastrointestinal (GI) research for people living with GI-immune mediated diseases.

BMS at EADV Congress 2022 >

The European Academy of Dermatology and Venereology (EADV) Congress 2022 serves as an important opportunity to engage in scientific exchange with the dermatology research and medical community.

BMS at ECTRIMS 2022 >

The Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022 represents an important milestone to engage with the neurology research and medical community.

BMS at AHA Scientific Sessions 2021 >

At the AHA 2021 Scientific Sessions, Bristol Myers Squibb shared updates from our robust cardiovascular pipeline and highlighted key research programs that propel discovery of treatment options for patients with cardiovascular disease.